Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID Pandemic, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the gravity and importance of antimicrobial resistance (AMR) clinical research and development, the potential impact of the COVID-19 pandemic and how we can turn the momentum into a positive for AMR research. They will also discuss the role of global AMR surveillance in clinical development.

In this webinar, we bring together AMR experts to discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for antibacterial drugs.

The World Health Organization (WHO) has identified antimicrobial resistance (AMR) as one of the biggest threats to global health. Despite the concerns raised by many in the public health community, the antibiotic pipeline is still quite limited and resistance to many antibiotics continues to grow. It is an ongoing silent pandemic that results in over 700,000 deaths each year.

The global COVID-19 pandemic heightened our understanding and awareness to the threat of infectious diseases, including drug-resistant infections. In this webinar, we bring together AMR experts to discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for antibacterial drugs. Key topics for discussion include:

  • Antibiotics and AMR: drug development pre-pandemic, impacts from COVID-19 and visions for post-pandemic realities
  • How global AMR surveillance programs and data mining of local and regional antibiograms can be leveraged to inform antimicrobial drug development and optimize clinical trials
  • How can we continue the momentum, the passion and awareness that was awakened by COVID-19 to other global threats like AMR?

Join experts Brian Murphy, MD, MPH, FIDSA, Vice-President, Medical Department, Medpace; Jennifer Schneider, PhD, Senior Advisor, External Affairs, GARDP; and Daniel F. Sahm, PhD, D(ABMM), FAAM, VP Global Microbiology Services & Chief Scientific Officer, IHMA, for the live webinar on Thursday, May 27, 2021 at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistant – Lessons Learned During the COVID Pandemic.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website